Top compounds associated with response to LUC7L2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Topotecan	CTRPv2	pan-cancer	AAC	0.18	3e-07
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.18	3e-07
mRNA	ciclopirox	CTRPv2	pan-cancer	AAC	0.18	3e-07
mRNA	Cytarabine	CTRPv2	pan-cancer	AAC	0.16	3e-07
mRNA	BRD-K34222889	CTRPv2	pan-cancer	AAC	0.17	4e-07
mRNA	SB-743921	CTRPv2	pan-cancer	AAC	0.18	4e-07
mRNA	BRD-K41597374	CTRPv2	pan-cancer	AAC	0.19	7e-07
mRNA	ISOX:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.19	7e-07
mRNA	manumycin A	CTRPv2	pan-cancer	AAC	0.17	8e-07
mRNA	alisertib	CTRPv2	pan-cancer	AAC	0.16	1e-06

Download CSV